Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells

[1]  Xiaofei Li,et al.  Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy , 2018, Cancer medicine.

[2]  Lian-Hua Fu,et al.  Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment. , 2018, Chemical Society reviews.

[3]  Feng Zhang,et al.  Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. , 2018, Chemico-biological interactions.

[4]  Feng Zhang,et al.  Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride‐induced liver fibrosis and hepatic stellate cell activation , 2018, International immunopharmacology.

[5]  Feng Zhang,et al.  Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF‐1α signaling , 2018, Journal of cellular biochemistry.

[6]  Feng Zhang,et al.  Oroxylin A inhibits ethanol‐induced hepatocyte senescence via YAP pathway , 2018, Cell proliferation.

[7]  Feng Zhang,et al.  Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α , 2018, Theranostics.

[8]  D. Tang,et al.  The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration , 2017, Respiratory Research.

[9]  Feng Zhang,et al.  Canonical hedgehog signalling regulates hepatic stellate cell‐mediated angiogenesis in liver fibrosis , 2017, British journal of pharmacology.

[10]  T. Kisseleva.  The origin of fibrogenic myofibroblasts in fibrotic liver , 2017, Hepatology.

[11]  F. Buss,et al.  Myosins: Domain Organisation, Motor Properties, Physiological Roles and Cellular Functions. , 2016, Handbook of experimental pharmacology.

[12]  K. Storey.  Comparative enzymology-new insights from studies of an "old" enzyme, lactate dehydrogenase. , 2016, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[13]  Aristeidis E. Boukouris,et al.  Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. , 2016, Trends in biochemical sciences.

[14]  Shiping Ma,et al.  Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia‐inducible factor‐1 in human hepatoma HepG2 cells , 2016, Molecular carcinogenesis.

[15]  Feng Zhang,et al.  Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate‐activated protein kinase , 2016, IUBMB life.

[16]  G. Di Stefano,et al.  Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment. , 2016, Future medicinal chemistry.

[17]  Feng Zhang,et al.  Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells , 2015, Laboratory Investigation.

[18]  N. Lu,et al.  Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization , 2015, Cell Death and Disease.

[19]  Qing-hua Zhou,et al.  Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy , 2015, Thoracic cancer.

[20]  Feng Zhang,et al.  Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways , 2014, Molecular and Cellular Endocrinology.

[21]  M. Vettraino,et al.  Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. , 2013, Biochemical and biophysical research communications.

[22]  C. Hellerbrand.  Hepatic stellate cells—the pericytes in the liver , 2013, Pflügers Archiv - European Journal of Physiology.

[23]  C. Piantadosi,et al.  Hedgehog controls hepatic stellate cell fate by regulating metabolism. , 2012, Gastroenterology.

[24]  S. Parkhurst,et al.  Cytoskeleton responses in wound repair , 2012, Cellular and Molecular Life Sciences.

[25]  Michael S. Carter,et al.  Biochemistry of smooth muscle myosin light chain kinase. , 2011, Archives of biochemistry and biophysics.

[26]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[27]  S. Takashima,et al.  Phosphorylation of myosin regulatory light chain by myosin light chain kinase, and muscle contraction. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[28]  H. Yee,et al.  Stellate cell contraction: role, regulation, and potential therapeutic target. , 2008, Clinics in liver disease.

[29]  W. Liu,et al.  Oroxylin A induces G2/M phase cell‐cycle arrest via inhibiting Cdk7‐mediated expression of Cdc2/p34 in human gastric carcinoma BGC‐823 cells , 2008 .

[30]  A. Geerts,et al.  Regulation of Sinusoidal Perfusion in Portal Hypertension , 2008, Anatomical record.

[31]  Yong Yang,et al.  Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. , 2006, Biochemical and biophysical research communications.

[32]  V. Faundez,et al.  Architecture of the vimentin cytoskeleton is modified by perturbation of the GTPase ARF1 , 2006, Journal of Cell Science.

[33]  D. Tang,et al.  Role of vimentin in smooth muscle force development. , 2006, American journal of physiology. Cell physiology.

[34]  S. Bonhoeffer,et al.  Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.

[35]  T. Gupta,et al.  Pathophysiology of portal hypertension. , 1997, Clinics in liver disease.

[36]  J. Liu,et al.  Metabolic regulation of gene transcription. , 1994, The Journal of nutrition.

[37]  Alexander V. Zhdanov,et al.  Cell energy budget platform for assessment of cell metabolism. , 2015, Methods in molecular biology.

[38]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[39]  Yong Yang,et al.  Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells. , 2008, The Journal of pharmacy and pharmacology.